 | Up a level |
Chaccour, Carlos; Ruiz-Castillo, Paula; Richardson, Mary-Ann; Moncunill, Gemma; Casellas, Aina; Carmona-Torre, Francisco; Giráldez, Miriam; Mota, Juana Schwartz; Yuste, José Ramón; Azanza, José Ramón; Fernández, Miriam; Reina, Gabriel; Dobaño, Carlota; Brew, Joe; Sadaba, Belen; Hammann, Felix; Rabinovich, Regina (2020). The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Trials, 21(1), p. 498. BioMed Central 10.1186/s13063-020-04421-z
